13-year-old innovator Jaiwardhan Tyagi IMPRESSES Aman Gupta and secures a deal on Shark Tank India Season 5
Three points you will get to know in this article:
1) 13-year-old entrepreneur Jaiwardhan Tyagi stunned the Sharks & secured a deal with Shark Aman
2) A clear explanation of Neurapex AI, its vision, and its core tools
3) Insights into Neurapex AI’s future goals, including new diagnostic modules
13 year old entrepreneur impresses the sharks with his innovation
Jaiwardhan Tyagi walks into Shark Tank India 5 and leaves the Sharks in a state of absolute disbelief. The young entrepreneur has come to show his very first creation, Neurapex AI.
Shark Tank India 5 Ep on January 19: A 13-year-old child from Ghaziabad named Jaiwardhan Tyagi enters the show and leaves the Sharks in complete shock. This is expected to be one of the most important and inspirational moments of Shark Tank India 5. Neurapex AI, a very advanced AI-powered Assistive Diagnostic Platform designed for medical professionals, particularly in the fields of neurology and dermatology, is the young entrepreneur’s first invention.
Despite being heavily tech-focused, Neurapex AI’s presentation on Shark Tank was straightforward and purpose-driven, with the founders emphasizing a solution that aids physicians and patients rather than taking the place of diagnosis.
Neurapex AI Vision

The goal of Neurapex AI is to use artificial intelligence to convert complicated medical data into clear, intelligible, and useful insights so that physicians, hospitals, and individuals may all make better decisions. The brand emphasizes that AI enhances physicians’ clinical judgment rather than replacing them.
About Neurapex AI

Neurapex AI is an AI-powered assistive diagnostic tool that employs AI to identify and track health issues early on.
Based on early warning indicators, the program particularly detects medical illnesses including dementia (like Alzheimer’s), mental health disorders, and skin concerns, sometimes offering insights even before symptoms manifest.
The goal of Neurapex’s solutions is to get around the drawbacks of conventional diagnostics, namely laborious processes and delayed detection.
With the use of AI that has been trained on thousands of medical data and photos, it offers specialist-grade insights, giving users and healthcare professionals quick and precise preliminary information.
Checkout the company website here: Neurapex AI
The core features of Neurapex AI include two main diagnostic tools:
- Alzmind: This module uses brain MRI analytics and multimodal AI reasoning to assess early stages of Alzheimer’s, neuro syndromes, and progression risk.
By analyzing MRI pictures, AI deep learning algorithms offer insights into risk projections and therapeutic choices. - Deepderm is a skin health assessment service that allows users to upload a photo and receive an AI-based diagnosis of more than fifty skin disorders. Multimodal deep learning pipelines offer diagnostic insights and are tailored for a range of skin tones.
Neurapex AI aims to make healthcare proactive so that individuals can take the right medical action by being aware of the early hazards rather than the symptoms that appear later. This instrument is intended to provide assistive diagnostic support for both
Neurapex is the future goals of AI
The creation of the product… incorporating new diagnostic modules, such as early cardiovascular or metabolic risk detection systems based on artificial intelligence. The integration of clinical practice… To incorporate AI insights into healthcare workflows, strengthen collaborations with hospitals, diagnostic facilities, and telehealth platforms.
- Accessibility and Outreach: Providing rural or underserved communities with AI-assisted healthcare technologies.
- Regulatory Permissions completing procedures for regulatory certifications and medical device validation in order to formally comply with safety and accuracy requirements.
About Neurapex AI Founder

Jaivardhan Tyagi, a young inventor and businessman, came up with the original idea for Neurapex AI. Jaivardhan is passionate about expanding access to technology-driven diagnostics and works at the nexus of AI and healthcare innovation.
According to him, Neurapex AI aims to empower and democratize health insights so that individuals can recognize early warning signals and promptly seek medical attention, rather than to replace doctors.
The Shark tank Pitch on Neurapex
Shark Kunal bahl was very impressed but he believes the product is not ready yet but he also quoted that when the product will be ready he would love to meet Jaiwardhan Tyagi & talk about it. He also mentioned that this is definitely the most inspiring pitch of season 5
Shark Namita said there is one big gap & is not still proof. She believes that the business needs a panel of doctors . That will improve the accuracy & she was out from the deal
Shark Vineeta commented that it is not investable as of now & walked out
Shark Ritesh Agarwal was quite impressed & proposed Jaiwardhan to come in his office & spend 1-2 days but he was out for the deal
Shark Aman wanted to support Jaiwardhan & secured a deal for 60 lakhs for 5 % equity
Conclusion
Neurapex AI’s path demonstrates that healthcare in the future will focus on early detection and prevention rather than merely therapy.
When symptoms are not yet readily apparent, AI-based assistive diagnostic technologies can prove to be beneficial support systems for both physicians and patients. The idea of Neurapex AI indicates the appropriate path for healthcare innovation, even though the investment details related to the Shark Tank episode have not yet been made public.
This platform has the potential to become a powerful example of AI-assisted diagnostics in India if the company is successful in obtaining regulatory permissions, clinical validation, and hospital integrations.
- Shesha Ayurveda: Bringing Kerala’s Herbal Beauty to Shark Tank India - January 31, 2026
- SPARSH BRUSH On Shark Tank India: Cattle care Brand - January 31, 2026
- From astrology to arcades: Shark Tank India pitcher hailed as ‘India’s Da Vinci’ but leaves empty-handed - January 31, 2026
